PRMT5 and pancreatic neoplasm: PRMT5 induces the phosphorylation of the epidermal growth factor receptor (EGFR), upregulates the expression of β-catenin through the EGFR/AKT/β-catenin pathway, and promotes the EMT of pancreatic cancer cells to enhance tumor migration and invasion [83].